Glenmark Pharmaceuticals today said it has received the final approval from the US drug regulator for the marketing of its anti- hypertension tablets.     

Glenmark Generics, a subsidiary firm of the company, has received the final approval from the US Food and Drug Administration (US FDA) for its hydralazine hydrochloride tablets, used for the treatment of hypertension, Glenmark Pharmaceuticals said in a filing to the Bombay Stock Exchange.     

Also Read   Related Stories News Now - Aurobindo Phrama gets USFDA nod for veterinary drug - Orchid Pharmaceuticals receive FDA nod for anti-migraine tablets - Ranbaxy: Catching the FDA flu - Suven hits 10% upper limit on US FDA nod - Suven gets US FDA nod for Nalgonda unit; scrip surges 10% - Ranbaxy makes voluntary recall of drug in US

Also Read   Related Stories News Now - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report More

According to an estimate, as on March 2009, the market size of anti-hypertension drugs in the US was over $55 million.     

Shares of Glenmark Pharma were trading at Rs 227, down 0.04 per cent in afternoon trade on the BSE.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report

Tags : Glenmark Pharmaceuticals | US FDA | hypertension | Pharma industry   Read Business news in  Advertisements -  Journey on, We are by Your Side. Click here to know more -  2 Lac Apartments, 1 Lac House / Plots. Click here -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  The Best Seller is Also the No. 1 in Mileage. Click here -  Watch The Film Here. Click here to know more.. -  Leader in Passenger Car & Automobile Tyres. Click here -  1 billion in saving for Unilever without any tangles. -  A Brand New Server at a Price That Fits Your Budget. Click here -  Learn How One City is Running on FOOD SCRAPS. -  One Partnership Endless Possibilities. Click here to know more -  Helping doctors detect diseases earlier, saving costs & extending lives. -  36 Lakhs can get you a pool of Luxuries. Click here -  Which is the best plan for your daughter -  Check out the TRUE COLOURS of your Stocks, Now for FREE! -  One of the leading business schools in the world.Know More